Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalMultiple Sclerosis Journal
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this